000 | 01972 a2200529 4500 | ||
---|---|---|---|
005 | 20250516100750.0 | ||
264 | 0 | _c20121102 | |
008 | 201211s 0 0 eng d | ||
022 | _a1522-1555 | ||
024 | 7 |
_a10.1152/ajpendo.00022.2012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGornicka, Agnieszka | |
245 | 0 | 0 |
_aAdipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Endocrinology and metabolism _cSep 2012 |
||
300 |
_aE597-606 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _a3T3-L1 Cells |
650 | 0 | 4 |
_aAdipocytes _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aDiet, High-Fat _xadverse effects |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aFatty Acids, Nonesterified _xadverse effects |
650 | 0 | 4 | _aHypertrophy |
650 | 0 | 4 |
_aLysosomes _xdrug effects |
650 | 0 | 4 |
_aMacrophage Activation _xdrug effects |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aObesity _xdrug therapy |
650 | 0 | 4 |
_aPermeability _xdrug effects |
650 | 0 | 4 |
_aProtein Transport _xdrug effects |
700 | 1 | _aFettig, Jade | |
700 | 1 | _aEguchi, Akiko | |
700 | 1 | _aBerk, Michael P | |
700 | 1 | _aThapaliya, Samjhana | |
700 | 1 | _aDixon, Laura J | |
700 | 1 | _aFeldstein, Ariel E | |
773 | 0 |
_tAmerican journal of physiology. Endocrinology and metabolism _gvol. 303 _gno. 5 _gp. E597-606 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpendo.00022.2012 _zAvailable from publisher's website |
999 |
_c21900015 _d21900015 |